Improving the monitoring of chronic heart failure in Argentina: is the implantable pulmonary artery pressure with CardioMEMS Heart Failure System cost-effective?
Andrea AlcarazCarlos Rojas-RoqueDaniela PrinaJuan Martín GonzálezAndrés Pichon-RiviereFederico AugustovskiAlfredo PalaciosPublished in: Cost effectiveness and resource allocation : C/E (2021)
CardioMEMS was more effective and more costly than usual care in class III HF patients. Since in Argentina there is no current explicit threshold, the final decision to determine its cost-effectiveness will depend on the willingness-to-pay for QALYs in each health subsector.
Keyphrases
- pulmonary artery
- heart failure
- ejection fraction
- healthcare
- end stage renal disease
- coronary artery
- pulmonary hypertension
- pulmonary arterial hypertension
- newly diagnosed
- palliative care
- public health
- chronic kidney disease
- mental health
- prognostic factors
- peritoneal dialysis
- acute heart failure
- atrial fibrillation
- quality improvement
- health information
- pain management
- chronic pain
- health insurance
- decision making
- climate change
- cardiac resynchronization therapy